Phase II Study of Intermediate-Dose Cytarabine in Patients With Relapsed or Refractory Ewing Sarcoma: A Report From the Children's Oncology Group
Pediatric Blood and Cancer - United States
doi 10.1002/pbc.21822
Full Text
Open PDFAbstract
Available in full text
Date
March 1, 2009
Authors
Publisher
Wiley